{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:16:10Z","timestamp":1790842570120,"version":"4.1.0"},"reference-count":272,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41380-020-00999-7","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T09:06:01Z","timestamp":1611565561000},"page":"2685-2706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders"],"prefix":"10.1038","volume":"26","author":[{"given":"Aur\u00e9lie","family":"de Rus Jacquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8na L.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1961","authenticated-orcid":false,"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Alpaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"999_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1128\/CMR.00046-15","volume":"29","author":"AS Das","year":"2016","unstructured":"Das AS, Zou WQ. Prions: beyond a single protein. Clin Microbiol Rev. 2016;29:633\u201358.","journal-title":"Clin Microbiol Rev"},{"key":"999_CR2","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1021\/bi00562a028","volume":"19","author":"SB Prusiner","year":"1980","unstructured":"Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochem. 1980;19:4883\u201391.","journal-title":"Biochem"},{"key":"999_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0928-8244(98)00020-0","volume":"21","author":"JW Ironside","year":"1998","unstructured":"Ironside JW. Neuropathological findings in new variant CJD and experimental transmission of BSE. FEMS Immunol Med Mic. 1998;21:91\u201395.","journal-title":"FEMS Immunol Med Mic"},{"key":"999_CR4","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1529\/biophysj.106.098608","volume":"92","author":"CC Lee","year":"2007","unstructured":"Lee CC, Nayak A, Sethuraman A, Belfort G, McRae GJ. A three-stage kinetic model of amyloid fibrillation. Biophys J. 2007;92:3448\u201358.","journal-title":"Biophys J"},{"key":"999_CR5","first-page":"49","volume":"1","author":"TB Ahn","year":"2012","unstructured":"Ahn TB, Langston JW, Aachi VR, Dickson DW. Relationship of neighboring tissue and gliosis to alpha-synuclein pathology in a fetal transplant for Parkinson\u2019s disease. Am J Neurodegen Dis. 2012;1:49\u201359.","journal-title":"Am J Neurodegen Dis"},{"key":"999_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1749-6632.2009.05229.x","volume":"1184","author":"Y Chu","year":"2010","unstructured":"Chu Y, Kordower JH. Lewy body pathology in fetal grafts. Ann NY Acad Sci. 2010;1184:55\u201367.","journal-title":"Ann NY Acad Sci."},{"key":"999_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med. 2008;14:504\u20136.","journal-title":"Nat Med"},{"key":"999_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med. 2008;14:501\u20133.","journal-title":"Nat Med"},{"key":"999_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"999_CR10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med. 2012;209:975\u201386.","journal-title":"J Exp Med"},{"key":"999_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B, Bove J, Carballo-Carbajal I, Dovero S, Perez-Villalba A, et al. Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol. 2014;75:351\u201362.","journal-title":"Ann Neurol"},{"key":"999_CR12","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1093\/brain\/awz329","volume":"142","author":"B Dehay","year":"2019","unstructured":"Dehay B, Bezard E. Intrastriatal injection of alpha-synuclein fibrils induces Parkinson-like pathology in macaques. Brain. 2019;142:3321\u20132.","journal-title":"Brain"},{"key":"999_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103:627\u201341 e627.","journal-title":"Neuron"},{"key":"999_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, et al. Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23:327\u201336.","journal-title":"Nat Neurosci."},{"key":"999_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orru CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, et al. Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alphaSyn RT-QuIC. Acta Neuropathol Commun. 2018;6:7.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR16","first-page":"142","volume":"5","author":"S Singh","year":"2020","unstructured":"Singh S, DeMarco ML. In vitro conversion assays diagnostic for neurodegenerative proteinopathies. JALM. 2020;5:142\u2013157.","journal-title":"JALM"},{"key":"999_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000116984","volume":"33","author":"H Braak","year":"1993","unstructured":"Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol. 1993;33:403\u20138.","journal-title":"Eur Neurol"},{"key":"999_CR18","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science. 2006;313:1781\u20134.","journal-title":"Science"},{"key":"999_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s40478-019-0771-x","volume":"7","author":"C Gary","year":"2019","unstructured":"Gary C, Lam S, Herard AS, Koch JE, Petit F, Gipchtein P, et al. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathol Commun. 2019;7:126.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR20","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. PNAS. 2013;110:9535\u201340.","journal-title":"PNAS"},{"key":"999_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06548-9","volume":"9","author":"S Porta","year":"2018","unstructured":"Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9:4220.","journal-title":"Nat Commun"},{"key":"999_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegen. 2011;6:39.","journal-title":"Mol Neurodegen"},{"key":"999_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3233\/JAD-151136","volume":"52","author":"CK Mulder","year":"2016","unstructured":"Mulder CK, Dong Y, Brugghe HF, Timmermans HA, Tilstra W, Westdijk J, et al. Immunization with small amyloid-beta-derived cyclopeptide conjugates diminishes amyloid-beta-induced neurodegeneration in mice. J Alzheimer\u2019s Dis. 2016;52:1111\u201323.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"999_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM, et al. Best practices for generating and using Alpha-synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents. J Parkinson\u2019s Dis. 2018;8:303\u201322.","journal-title":"J Parkinson\u2019s Dis"},{"key":"999_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00401-019-01973-6","volume":"137","author":"M Masnata","year":"2019","unstructured":"Masnata M, Sciacca G, Maxan A, Bousset L, Denis HL, Lauruol F, et al. Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms. Acta Neuropathol. 2019;137:981\u20131001.","journal-title":"Acta Neuropathol"},{"key":"999_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-015-0053-4","volume":"10","author":"R Zeineddine","year":"2015","unstructured":"Zeineddine R, Pundavela JF, Corcoran L, Stewart EM, Do-Ha D, Bax M, et al. SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation. Mol Neurodegen. 2015;10:57.","journal-title":"Mol Neurodegen"},{"key":"999_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S. Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat. 2014;8:155.","journal-title":"Front Neuroanat"},{"key":"999_CR28","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","volume":"21","author":"TM Dawson","year":"2018","unstructured":"Dawson TM, Golde TE, Lagier-Tourenne C. Animal models of neurodegenerative diseases. Nat Neurosci. 2018;21:1370\u20139.","journal-title":"Nat Neurosci"},{"key":"999_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/cns.12839","volume":"24","author":"SM Holley","year":"2018","unstructured":"Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, et al. Therapeutic effects of stem cells in rodent models of Huntington\u2019s disease: Review and electrophysiological findings. CNS Neurosci Ther. 2018;24:329\u201342.","journal-title":"CNS Neurosci Ther"},{"key":"999_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","volume":"12","author":"JL Jankowsky","year":"2017","unstructured":"Jankowsky JL, Zheng H. Practical considerations for choosing a mouse model of Alzheimer\u2019s disease. Mol Neurodegen. 2017;12:89.","journal-title":"Mol Neurodegen"},{"key":"999_CR31","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1523\/JNEUROSCI.4707-08.2009","volume":"29","author":"NA Oberheim","year":"2009","unstructured":"Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29:3276\u201387.","journal-title":"J Neurosci"},{"key":"999_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stem.2012.12.015","volume":"12","author":"X Han","year":"2013","unstructured":"Han X, Chen M, Wang F, Windrem M, Wang S, Shanz S, et al. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell. 2013;12:342\u201353.","journal-title":"Cell Stem Cell"},{"key":"999_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37\u201353.","journal-title":"Neuron"},{"key":"999_CR34","doi-asserted-by":"publisher","first-page":"eaba7667","DOI":"10.1126\/science.aba7667","volume":"369","author":"T Rayon","year":"2020","unstructured":"Rayon T, Stamataki D, Perez-Carrasco R, Garcia-Perez L, Barrington C, Melchionda M, et al. Species-specific pace of development is associated with differences in protein stability. Science. 2020;369:eaba7667.","journal-title":"Science"},{"key":"999_CR35","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB. Prions. PNAS. 1998;95:13363\u201383.","journal-title":"PNAS"},{"key":"999_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3201\/eid2001.130858","volume":"20","author":"MA Barria","year":"2014","unstructured":"Barria MA, Balachandran A, Morita M, Kitamoto T, Barron R, Manson J, et al. Molecular barriers to zoonotic transmission of prions. Emerg Infect Dis. 2014;20:88\u201397.","journal-title":"Emerg Infect Dis"},{"key":"999_CR37","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1128\/JVI.02296-14","volume":"89","author":"FK Wiseman","year":"2015","unstructured":"Wiseman FK, Cancellotti E, Piccardo P, Iremonger K, Boyle A, Brown D, et al. The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species. J Virol. 2015;89:4738\u201347.","journal-title":"J Virol"},{"key":"999_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4161\/pri.23122","volume":"7","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa K, Mohri S, Yokoyama T. Comparison of the local structural stabilities of mammalian prion protein (PrP) by fragment molecular orbital calculations. Prion. 2013;7:185\u201391.","journal-title":"Prion"},{"key":"999_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.07.011","volume":"119","author":"J Sanchez-Garcia","year":"2018","unstructured":"Sanchez-Garcia J, Fernandez-Funez P. D159 and S167 are protective residues in the prion protein from dog and horse, two prion-resistant animals. Neurobiol Dis. 2018;119:1\u201312.","journal-title":"Neurobiol Dis"},{"key":"999_CR40","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1093\/emboj\/20.18.5070","volume":"20","author":"RM Barron","year":"2001","unstructured":"Barron RM, Thomson V, Jamieson E, Melton DW, Ironside J, Will R, et al. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J. 2001;20:5070\u20138.","journal-title":"EMBO J"},{"key":"999_CR41","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1073\/pnas.2627989100","volume":"100","author":"C Korth","year":"2003","unstructured":"Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. PNAS. 2003;100:4784\u20139.","journal-title":"PNAS"},{"key":"999_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnagi.2020.00011","volume":"12","author":"F Hernandez","year":"2020","unstructured":"Hernandez F, Merchan-Rubira J, Valles-Saiz L, Rodriguez-Matellan A, Avila J. Differences between human and murine tau at the N-terminal end. Front Aging Neurosci. 2020;12:11.","journal-title":"Front Aging Neurosci"},{"key":"999_CR43","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.bbadis.2018.08.010","volume":"1865","author":"F Hernandez","year":"2019","unstructured":"Hernandez F, Cuadros R, Olla I, Garcia C, Ferrer I, Perry G, et al. Differences in structure and function between human and murine tau. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2024\u201330.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Pt 4","key":"999_CR44","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/brain\/awg090","volume":"126","author":"PM Stanford","year":"2003","unstructured":"Stanford PM, Shepherd CE, Halliday GM, Brooks WS, Schofield PW, Brodaty H, et al. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain. 2003;126(Pt 4):814\u201326.","journal-title":"Brain"},{"key":"999_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702\u20135.","journal-title":"Nature"},{"key":"999_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-020-0887-z","volume":"8","author":"MA Metrick II","year":"2020","unstructured":"Metrick MA II, Ferreira NDC, Saijo E, Kraus A, Newell K, Zanusso G, et al. A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases. Acta Neuropathol Commun. 2020;8:22.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR47","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/WAD.0b013e31815bf5e5","volume":"21","author":"WT Hu","year":"2007","unstructured":"Hu WT, Parisi JE, Knopman DS, Boeve BF, Dickson DW, Ahlskog JE, et al. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Alzheimer Dis Assoc Disord. 2007;21:S39\u201343.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"999_CR48","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1021\/bi2004685","volume":"50","author":"PD Dinkel","year":"2011","unstructured":"Dinkel PD, Siddiqua A, Huynh H, Shah M, Margittai M. Variations in filament conformation dictate seeding barrier between three- and four-repeat tau. Biochemistry. 2011;50:4330\u20136.","journal-title":"Biochemistry"},{"key":"999_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/JAD-131106","volume":"37","author":"L Levarska","year":"2013","unstructured":"Levarska L, Zilka N, Jadhav S, Neradil P, Novak M. Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2013;37:569\u201377.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"999_CR50","doi-asserted-by":"publisher","first-page":"e0210864","DOI":"10.1371\/journal.pone.0210864","volume":"14","author":"CL Sayas","year":"2019","unstructured":"Sayas CL, Medina M, Cuadros R, Olla I, Garcia E, Perez M, et al. Role of tau N-terminal motif in the secretion of human tau by End Binding proteins. PLoS ONE. 2019;14:e0210864.","journal-title":"PLoS ONE."},{"key":"999_CR51","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1021\/bi501239q","volume":"53","author":"H Ueno","year":"2014","unstructured":"Ueno H, Yamaguchi T, Fukunaga S, Okada Y, Yano Y, Hoshino M, et al. Comparison between the aggregation of human and rodent amyloid beta-proteins in GM1 ganglioside clusters. Biochemistry. 2014;53:7523\u201330.","journal-title":"Biochemistry"},{"key":"999_CR52","doi-asserted-by":"publisher","first-page":"22707","DOI":"10.1074\/jbc.M611050200","volume":"282","author":"JL Jankowsky","year":"2007","unstructured":"Jankowsky JL, Younkin LH, Gonzales V, Fadale DJ, Slunt HH, Lester HA, et al. Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem. 2007;282:22707\u201320.","journal-title":"J Biol Chem"},{"key":"999_CR53","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","volume":"20","author":"MD Kane","year":"2000","unstructured":"Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, et al. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci. 2000;20:3606\u201311.","journal-title":"J Neurosci"},{"key":"999_CR54","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.bbadis.2019.02.013","volume":"1865","author":"G Tanaka","year":"2019","unstructured":"Tanaka G, Yamanaka T, Furukawa Y, Kajimura N, Mitsuoka K, Nukina N. Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1410\u201320.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"999_CR55","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1016\/j.celrep.2016.08.053","volume":"16","author":"KC Luk","year":"2016","unstructured":"Luk KC, Covell DJ, Kehm VM, Zhang B, Song IY, Byrne MD, et al. Molecular and biological compatibility with host alpha-synuclein influences fibril pathogenicity. Cell Rep. 2016;16:3373\u201387.","journal-title":"Cell Rep"},{"key":"999_CR56","doi-asserted-by":"publisher","first-page":"E912","DOI":"10.1073\/pnas.1512876113","volume":"113","author":"MB Fares","year":"2016","unstructured":"Fares MB, Maco B, Oueslati A, Rockenstein E, Ninkina N, Buchman VL, et al. Induction of de novo alpha-synuclein fibrillization in a neuronal model for Parkinson\u2019s disease. PNAS. 2016;113:E912\u2013921.","journal-title":"PNAS"},{"key":"999_CR57","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/molbev\/msm258","volume":"25","author":"M Tartari","year":"2008","unstructured":"Tartari M, Gissi C, Lo Sardo V, Zuccato C, Picardi E, Pesole G, et al. Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin. Mol Biol Evol. 2008;25:330\u20138.","journal-title":"Mol Biol Evol"},{"key":"999_CR58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369:218\u201328.","journal-title":"Lancet"},{"key":"999_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol. 2003;465:11\u201326.","journal-title":"J Comp Neurol"},{"key":"999_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","volume":"32","author":"MY Heng","year":"2008","unstructured":"Heng MY, Detloff PJ, Albin RL. Rodent genetic models of Huntington disease. Neurobiol Dis. 2008;32:1\u20139.","journal-title":"Neurobiol Dis"},{"key":"999_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.abb.2010.08.014","volume":"503","author":"SV Seetharaman","year":"2010","unstructured":"Seetharaman SV, Taylor AB, Holloway S, Hart PJ. Structures of mouse SOD1 and human\/mouse SOD1 chimeras. Arch Biochem Biophys. 2010;503:183\u201390.","journal-title":"Arch Biochem Biophys"},{"key":"999_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.abb.2010.07.027","volume":"503","author":"CM Karch","year":"2010","unstructured":"Karch CM, Borchelt DR. Aggregation modulating elements in mutant human superoxide dismutase 1. Arch Biochem Biophys. 2010;503:175\u201382.","journal-title":"Arch Biochem Biophys"},{"key":"999_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0888-7543(03)00214-3","volume":"83","author":"HY Wang","year":"2004","unstructured":"Wang HY, Wang IF, Bose J, Shen CK. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics. 2004;83:130\u20139.","journal-title":"Genomics"},{"key":"999_CR64","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1261\/rna.047647.114","volume":"21","author":"S D\u2019Alton","year":"2015","unstructured":"D\u2019Alton S, Altshuler M, Lewis J. Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis. RNA. 2015;21:1419\u201332.","journal-title":"RNA"},{"key":"999_CR65","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.3390\/ijms20235866","volume":"20","author":"V Gumina","year":"2019","unstructured":"Gumina V, Onesto E, Colombrita C, Maraschi A, Silani V, Ratti A. Inter-species differences in regulation of the progranulin-Sortilin axis in TDP-43 Cell models of neurodegeneration. Int J Mol Sci. 2019;20:5866.","journal-title":"Int J Mol Sci."},{"key":"999_CR66","doi-asserted-by":"publisher","first-page":"20914","DOI":"10.1073\/pnas.0710152105","volume":"104","author":"DW Colby","year":"2007","unstructured":"Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, et al. Prion detection by an amyloid seeding assay. PNAS. 2007;104:20914\u20139.","journal-title":"PNAS"},{"key":"999_CR67","doi-asserted-by":"publisher","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010;6:e1001217.","journal-title":"PLoS Pathog"},{"key":"999_CR68","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411:810\u20133.","journal-title":"Nature"},{"key":"999_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/40876","volume":"388","author":"GJ Raymond","year":"1997","unstructured":"Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, Bossers A, et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature. 1997;388:285\u20138.","journal-title":"Nature"},{"key":"999_CR70","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/bs.pmbts.2017.06.003","volume":"150","author":"B Caughey","year":"2017","unstructured":"Caughey B, Orru CD, Groveman BR, Hughson AG, Manca M, Raymond LD, et al. Amplified detection of prions and other amyloids by RT-QuIC in diagnostics and the evaluation of therapeutics and disinfectants. Prog Mol Biol Transl Sci. 2017;150:375\u201388.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"999_CR71","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.jmb.2019.05.036","volume":"431","author":"A Soto-Gamez","year":"2019","unstructured":"Soto-Gamez A, Quax WJ, Demaria M. Regulation of survival networks in senescent cells: from mechanisms to interventions. J Mol Biol. 2019;431:2629\u201343.","journal-title":"J Mol Biol"},{"key":"999_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/spmg.19885","volume":"2","author":"G Kaur","year":"2012","unstructured":"Kaur G, Dufour JM. Cell lines: valuable tools or useless artifacts. Spermatogenesis. 2012;2:1\u20135.","journal-title":"Spermatogenesis"},{"key":"999_CR73","first-page":"E3138","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. PNAS. 2013;110:E3138\u20133147.","journal-title":"PNAS"},{"key":"999_CR74","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1016\/j.celrep.2018.03.021","volume":"22","author":"LD Evans","year":"2018","unstructured":"Evans LD, Wassmer T, Fraser G, Smith J, Perkinton M, Billinton A, et al. Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways. Cell Rep. 2018;22:3612\u201324.","journal-title":"Cell Rep"},{"key":"999_CR75","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbadis.2016.12.015","volume":"1863","author":"AH Jansen","year":"2017","unstructured":"Jansen AH, Batenburg KL, Pecho-Vrieseling E, Reits EA. Visualization of prion-like transfer in Huntington\u2019s disease models. Biochim Biophys Acta Mol Basis Dis. 2017;1863:793\u2013800.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"999_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-020-03399-6","volume":"15","author":"BJ Jurgielewicz","year":"2020","unstructured":"Jurgielewicz BJ, Yao Y, Stice SL. Kinetics and specificity of HEK293T extracellular vesicle uptake using imaging flow cytometry. Nanoscale Res Lett. 2020;15:170.","journal-title":"Nanoscale Res Lett"},{"key":"999_CR77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neulet.2019.01.055","volume":"701","author":"M Heravi","year":"2019","unstructured":"Heravi M, Dargahi L, Parsafar S, Tayaranian Marvian A, Aliakbari F, Morshedi D. The primary neuronal cells are more resistant than PC12 cells to alpha-synuclein toxic aggregates. Neurosci Lett. 2019;701:38\u201347.","journal-title":"Neurosci Lett"},{"key":"999_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59213-x","volume":"10","author":"L Deng","year":"2020","unstructured":"Deng L, Pollmeier L, Zhou Q, Bergemann S, Bode C, Hein L, et al. Gene expression in immortalized versus primary isolated cardiac endothelial cells. Sci Rep. 2020;10:2241.","journal-title":"Sci Rep"},{"key":"999_CR79","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbrc.2006.10.020","volume":"351","author":"JH Kang","year":"2006","unstructured":"Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, Chung DH. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochem Biophys Res Commun. 2006;351:192\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"999_CR80","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nrm3190","volume":"12","author":"M Evans","year":"2011","unstructured":"Evans M. Discovering pluripotency: 30 years of mouse embryonic stem cells. Nat Rev Mol Cell Biol. 2011;12:680\u20136.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"999_CR81","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"999_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"IH Park","year":"2008","unstructured":"Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141\u20136.","journal-title":"Nature"},{"key":"999_CR83","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917\u201320.","journal-title":"Science"},{"key":"999_CR84","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.3390\/ijms20163862","volume":"20","author":"M Suga","year":"2019","unstructured":"Suga M, Kondo T, Inoue H. Modeling neurological disorders with human pluripotent stem cell-derived astrocytes. Int J Mol Sci. 2019;20:3862.","journal-title":"Int J Mol Sci."},{"key":"999_CR85","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3390\/molecules25082000","volume":"25","author":"CY Chang","year":"2020","unstructured":"Chang CY, Ting HC, Liu CA, Su HL, Chiou TW, Lin SZ, et al. Induced pluripotent stem cell (iPSC)-based neurodegenerative disease models for phenotype recapitulation and drug screening. Molecules. 2020;25:2000.","journal-title":"Molecules."},{"key":"999_CR86","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/glia.23733","volume":"68","author":"K Chanoumidou","year":"2020","unstructured":"Chanoumidou K, Mozafari S, Baron-Van Evercooren A, Kuhlmann T. Stem cell derived oligodendrocytes to study myelin diseases. Glia. 2020;68:705\u201320.","journal-title":"Glia"},{"key":"999_CR87","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/glia.23781","volume":"68","author":"J Hasselmann","year":"2020","unstructured":"Hasselmann J, Blurton-Jones M. Human iPSC-derived microglia: a growing toolset to study the brain\u2019s innate immune cells. Glia. 2020;68:721\u201339.","journal-title":"Glia"},{"key":"999_CR88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong W, Wang Z, Liu W, O\u2019Malley TT, Jin M, Willem M, et al. Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer\u2019s disease brain. Acta Neuropathol. 2018;136:19\u201340.","journal-title":"Acta Neuropathol"},{"key":"999_CR89","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nbd.2017.06.005","volume":"106","author":"P Reilly","year":"2017","unstructured":"Reilly P, Winston CN, Baron KR, Trejo M, Rockenstein EM, Akers JC, et al. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol Dis. 2017;106:222\u201334.","journal-title":"Neurobiol Dis"},{"key":"999_CR90","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10:615\u201322.","journal-title":"Nat Neurosci"},{"key":"999_CR91","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, et al. Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in parkinson\u2019s disease. Stem Cell Rep. 2019;12:213\u201329.","journal-title":"Stem Cell Rep"},{"key":"999_CR92","doi-asserted-by":"publisher","first-page":"141ra190","DOI":"10.1126\/scitranslmed.3003985","volume":"4","author":"O Cooper","year":"2012","unstructured":"Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson\u2019s disease. Sci Transl Med. 2012;4:141ra190.","journal-title":"Sci Transl Med"},{"key":"999_CR93","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5607\/en.2018.27.5.350","volume":"27","author":"L Li","year":"2018","unstructured":"Li L, Roh JH, Chang EH, Lee Y, Lee S, Kim M, et al. iPSC modeling of presenilin1 mutation in Alzheimer\u2019s disease with cerebellar ataxia. Exp Neurobiol. 2018;27:350\u201364.","journal-title":"Exp Neurobiol"},{"key":"999_CR94","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20132451","volume":"211","author":"JK Lee","year":"2014","unstructured":"Lee JK, Jin HK, Park MH, Kim BR, Lee PH, Nakauchi H, et al. Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer\u2019s disease. J Exp Med. 2014;211:1551\u201370.","journal-title":"J Exp Med"},{"key":"999_CR95","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.15252\/embj.201694401","volume":"35","author":"CP Webster","year":"2016","unstructured":"Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO. 2016;35:1656\u201376.","journal-title":"EMBO"},{"key":"999_CR96","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/v11030261","volume":"11","author":"C Scialo","year":"2019","unstructured":"Scialo C, De Cecco E, Manganotti P, Legname G. Prion and prion-like protein strains: deciphering the molecular basis of heterogeneity in neurodegeneration. Viruses. 2019;11:261.","journal-title":"Viruses."},{"key":"999_CR97","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nbd.2012.05.021","volume":"48","author":"X Chai","year":"2012","unstructured":"Chai X, Dage JL, Citron M. Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol Dis. 2012;48:356\u201366.","journal-title":"Neurobiol Dis"},{"key":"999_CR98","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","volume":"36","author":"J Bright","year":"2015","unstructured":"Bright J, Hussain S, Dang V, Wright S, Cooper B, Byun T, et al. Human secreted tau increases amyloid-beta production. Neurobiol Aging. 2015;36:693\u2013709.","journal-title":"Neurobiol Aging"},{"key":"999_CR99","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.celrep.2015.03.068","volume":"11","author":"S Moore","year":"2015","unstructured":"Moore S, Evans LD, Andersson T, Portelius E, Smith J, Dias TB, et al. APP metabolism regulates tau proteostasis in human cerebral cortex neurons. Cell Rep. 2015;11:689\u201396.","journal-title":"Cell Rep"},{"key":"999_CR100","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.nbd.2014.07.003","volume":"77","author":"JF Reyes","year":"2015","unstructured":"Reyes JF, Olsson TT, Lamberts JT, Devine MJ, Kunath T, Brundin P. A cell culture model for monitoring alpha-synuclein cell-to-cell transfer. Neurobiol Dis. 2015;77:266\u201375.","journal-title":"Neurobiol Dis"},{"key":"999_CR101","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nn.3761","volume":"17","author":"E Pecho-Vrieseling","year":"2014","unstructured":"Pecho-Vrieseling E, Rieker C, Fuchs S, Bleckmann D, Esposito MS, Botta P, et al. Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons. Nat Neurosci. 2014;17:1064\u201372.","journal-title":"Nat Neurosci"},{"key":"999_CR102","doi-asserted-by":"publisher","first-page":"10851","DOI":"10.1523\/JNEUROSCI.0387-15.2015","volume":"35","author":"D Kanmert","year":"2015","unstructured":"Kanmert D, Cantlon A, Muratore CR, Jin M, O\u2019Malley TT, Lee G, et al. C-terminally truncated forms of Tau, but not full-length Tau or its C-terminal fragments, are released from neurons independently of cell death. J Neurosci. 2015;35:10851\u201365.","journal-title":"J Neurosci"},{"key":"999_CR103","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/ijms19030663","volume":"19","author":"FX Guix","year":"2018","unstructured":"Guix FX, Corbett GT, Cha DJ, Mustapic M, Liu W, Mengel D, et al. Detection of aggregation-competent tau in neuron-derived extracellular vesicles. Int J Mol Sci. 2018;19:663.","journal-title":"Int J Mol Sci."},{"key":"999_CR104","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","volume":"35","author":"M Usenovic","year":"2015","unstructured":"Usenovic M, Niroomand S, Drolet RE, Yao L, Gaspar RC, Hatcher NG, et al. Internalized Tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells. J Neurosci. 2015;35:14234\u201350.","journal-title":"J Neurosci"},{"key":"999_CR105","doi-asserted-by":"publisher","first-page":"e0146127","DOI":"10.1371\/journal.pone.0146127","volume":"10","author":"A Verheyen","year":"2015","unstructured":"Verheyen A, Diels A, Dijkmans J, Oyelami T, Meneghello G, Mertens L, et al. Using human iPSC-derived neurons to model TAU aggregation. PLoS ONE. 2015;10:e0146127.","journal-title":"PLoS ONE"},{"key":"999_CR106","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.1713129115","volume":"115","author":"I Prots","year":"2018","unstructured":"Prots I, Grosch J, Brazdis RM, Simmnacher K, Veber V, Havlicek S, et al. Alpha-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. PNAS. 2018;115:7813\u20138.","journal-title":"PNAS"},{"key":"999_CR107","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.stemcr.2016.08.001","volume":"7","author":"MC Silva","year":"2016","unstructured":"Silva MC, Cheng C, Mair W, Almeida S, Fong H, Biswas MHU, et al. Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability. Stem Cell Rep. 2016;7:325\u201340.","journal-title":"Stem Cell Rep"},{"key":"999_CR108","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s12035-017-0506-6","volume":"55","author":"A Matamoros-Angles","year":"2018","unstructured":"Matamoros-Angles A, Gayosso LM, Richaud-Patin Y, di Domenico A, Vergara C, Hervera A, et al. iPS cell cultures from a Gerstmann-Straussler-Scheinker patient with the Y218N PRNP mutation recapitulate tau pathology. Mol Neurobiol. 2018;55:3033\u201348.","journal-title":"Mol Neurobiol"},{"key":"999_CR109","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1074\/jbc.RA118.005364","volume":"294","author":"HH Jarosz-Griffiths","year":"2019","unstructured":"Jarosz-Griffiths HH, Corbett NJ, Rowland HA, Fisher K, Jones AC, Baron J, et al. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-beta oligomers. J Biol Chem. 2019;294:7085\u201397.","journal-title":"J Biol Chem"},{"key":"999_CR110","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.stemcr.2018.12.007","volume":"12","author":"S Gribaudo","year":"2019","unstructured":"Gribaudo S, Tixador P, Bousset L, Fenyi A, Lino P, Melki R, et al. Propagation of alpha-Synuclein Strains within human reconstructed neuronal network. Stem Cell Rep. 2019;12:230\u201344.","journal-title":"Stem Cell Rep"},{"key":"999_CR111","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M, et al. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol. 2020;139:503\u201326.","journal-title":"Acta Neuropathol"},{"key":"999_CR112","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285:9262\u201372.","journal-title":"J Biol Chem"},{"key":"999_CR113","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","volume":"82","author":"V Lindstrom","year":"2017","unstructured":"Lindstrom V, Gustafsson G, Sanders LH, Howlett EH, Sigvardson J, Kasrayan A, et al. Extensive uptake of alpha-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neuro. 2017;82:143\u201356.","journal-title":"Mol Cell Neuro"},{"key":"999_CR114","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2047-9158-2-20","volume":"2","author":"N Braidy","year":"2013","unstructured":"Braidy N, Gai WP, Xu YH, Sachdev P, Guillemin GJ, Jiang XM, et al. Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts. Transl Neuro. 2013;2:20.","journal-title":"Transl Neuro"},{"key":"999_CR115","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nbd.2017.04.011","volume":"103","author":"F Cavaliere","year":"2017","unstructured":"Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M, et al. In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Neurobiol Dis. 2017;103:101\u201312.","journal-title":"Neurobiol Dis"},{"key":"999_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp SC, Lin Y, Oakley D, Roe AD, DeVos SL, Hanlon D, et al. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease. J Neuroinflam. 2018;15:269.","journal-title":"J Neuroinflam"},{"key":"999_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/srep11161","volume":"5","author":"W Luo","year":"2015","unstructured":"Luo W, Liu W, Hu X, Hanna M, Caravaca A, Paul SM. Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody. Sci Rep. 2015;5:11161.","journal-title":"Sci Rep"},{"key":"999_CR118","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1084\/jem.20172158","volume":"215","author":"H Martini-Stoica","year":"2018","unstructured":"Martini-Stoica H, Cole AL, Swartzlander DB, Chen F, Wan YW, Bajaj L, et al. TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J Exp Med. 2018;215:2355\u201377.","journal-title":"J Exp Med"},{"key":"999_CR119","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nm838","volume":"9","author":"T Wyss-Coray","year":"2003","unstructured":"Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med. 2003;9:453\u20137.","journal-title":"Nat Med"},{"key":"999_CR120","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","volume":"17","author":"DM Paresce","year":"1996","unstructured":"Paresce DM, Ghosh RN, Maxfield FR. Microglial cells internalize aggregates of the Alzheimer\u2019s disease amyloid beta-protein via a scavenger receptor. Neuron. 1996;17:553\u201365.","journal-title":"Neuron"},{"key":"999_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7768","volume":"6","author":"MMP Pearce","year":"2015","unstructured":"Pearce MMP, Spartz EJ, Hong W, Luo L, Kopito RR. Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat Commun. 2015;6:6768.","journal-title":"Nat Commun"},{"key":"999_CR122","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98:1141\u201354 e1147.","journal-title":"Neuron"},{"key":"999_CR123","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","volume":"9","author":"M Oksanen","year":"2017","unstructured":"Oksanen M, Petersen AJ, Naumenko N, Puttonen K, Lehtonen S, Gubert Olive M, et al. PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in Alzheimer\u2019s disease. Stem Cell Rep. 2017;9:1885\u201397.","journal-title":"Stem Cell Rep"},{"key":"999_CR124","doi-asserted-by":"publisher","first-page":"11341","DOI":"10.1074\/jbc.RA117.000441","volume":"293","author":"LK Fong","year":"2018","unstructured":"Fong LK, Yang MM, Dos Santos Chaves R, Reyna SM, Langness VF, Woodruff G, et al. Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-beta clearance in human astrocytes. J Biol Chem. 2018;293:11341\u201357.","journal-title":"J Biol Chem"},{"key":"999_CR125","unstructured":"Lorenzini I, Alsop E, Levy J, Gittings LM, Rabichow BE, lall d, et al. Activated iPSC-microglia from C9orf72 ALS\/FTD patients exhibit endosomal-lysosomal dysfunction. bioRxiv. 2020:277459."},{"key":"999_CR126","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","volume":"37","author":"J Rostami","year":"2017","unstructured":"Rostami J, Holmqvist S, Lindstrom V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated Alpha-Synuclein via tunneling nanotubes. J Neurosci. 2017;37:11835\u201353.","journal-title":"J Neurosci"},{"key":"999_CR127","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1084\/jem.20161547","volume":"214","author":"Z Krejciova","year":"2017","unstructured":"Krejciova Z, Alibhai J, Zhao C, Krencik R, Rzechorzek NM, Ullian EM, et al. Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner. J Exp Med. 2017;214:3481\u201395.","journal-title":"J Exp Med"},{"key":"999_CR128","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature. 2012;482:216\u201320.","journal-title":"Nature"},{"key":"999_CR129","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","volume":"9","author":"A Ochalek","year":"2017","unstructured":"Ochalek A, Mihalik B, Avci HX, Chandrasekaran A, Teglasi A, Bock I, et al. Neurons derived from sporadic Alzheimer\u2019s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation. Alzheimer\u2019s Res Ther. 2017;9:90.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"999_CR130","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/s41591-018-0140-5","volume":"24","author":"K Fujimori","year":"2018","unstructured":"Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24:1579\u201389.","journal-title":"Nat Med"},{"key":"999_CR131","doi-asserted-by":"publisher","first-page":"101541","DOI":"10.1016\/j.scr.2019.101541","volume":"40","author":"L Miguel","year":"2019","unstructured":"Miguel L, Rovelet-Lecrux A, Feyeux M, Frebourg T, Nassoy P, Campion D, et al. Detection of all adult Tau isoforms in a 3D culture model of iPSC-derived neurons. Stem Cell Res. 2019;40:101541.","journal-title":"Stem Cell Res"},{"key":"999_CR132","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2015.05.004","volume":"16","author":"L Studer","year":"2015","unstructured":"Studer L, Vera E, Cornacchia D. Programming and reprogramming cellular age in the era of induced pluripotency. Cell Stem Cell. 2015;16:591\u2013600.","journal-title":"Cell Stem Cell"},{"key":"999_CR133","doi-asserted-by":"publisher","first-page":"eaaw6404","DOI":"10.1126\/sciadv.aaw6404","volume":"5","author":"S Wegmann","year":"2019","unstructured":"Wegmann S, Bennett RE, Delorme L, Robbins AB, Hu M, McKenzie D, et al. Experimental evidence for the age dependence of tau protein spread in the brain. Sci Adv. 2019;5:eaaw6404.","journal-title":"Sci Adv"},{"key":"999_CR134","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-016-0092-5","volume":"11","author":"ED Nekrasov","year":"2016","unstructured":"Nekrasov ED, Vigont VA, Klyushnikov SA, Lebedeva OS, Vassina EM, Bogomazova AN, et al. Manifestation of Huntington\u2019s disease pathology in human induced pluripotent stem cell-derived neurons. Mol Neurodegen. 2016;11:27.","journal-title":"Mol Neurodegen."},{"key":"999_CR135","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller JD, Ganat YM, Kishinevsky S, Bowman RL, Liu B, Tu EY, et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell. 2013;13:691\u2013705.","journal-title":"Cell Stem Cell"},{"key":"999_CR136","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463:1035\u201341.","journal-title":"Nature"},{"key":"999_CR137","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1073\/pnas.1105135108","volume":"108","author":"U Pfisterer","year":"2011","unstructured":"Pfisterer U, Kirkeby A, Torper O, Wood J, Nelander J, Dufour A, et al. Direct conversion of human fibroblasts to dopaminergic neurons. PNAS. 2011;108:10343\u20138.","journal-title":"PNAS"},{"key":"999_CR138","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature10284","volume":"476","author":"M Caiazzo","year":"2011","unstructured":"Caiazzo M, Dell\u2019Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011;476:224\u20137.","journal-title":"Nature"},{"key":"999_CR139","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.stem.2017.08.002","volume":"21","author":"DG Abernathy","year":"2017","unstructured":"Abernathy DG, Kim WK, McCoy MJ, Lake AM, Ouwenga R, Lee SW, et al. MicroRNAs induce a permissive chromatin environment that enables neuronal subtype-specific reprogramming of adult human fibroblasts. Cell Stem Cell. 2017;21:332\u201348 e339.","journal-title":"Cell Stem Cell"},{"key":"999_CR140","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41593-018-0075-7","volume":"21","author":"MB Victor","year":"2018","unstructured":"Victor MB, Richner M, Olsen HE, Lee SW, Monteys AM, Ma C, et al. Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat Neurosci. 2018;21:341\u201352.","journal-title":"Nat Neurosci"},{"key":"999_CR141","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.mcn.2013.07.007","volume":"56","author":"MF Burkhardt","year":"2013","unstructured":"Burkhardt MF, Martinez FJ, Wright S, Ramos C, Volfson D, Mason M, et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci. 2013;56:355\u201364.","journal-title":"Mol Cell Neurosci"},{"key":"999_CR142","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-017-0268-4","volume":"9","author":"C Arber","year":"2017","unstructured":"Arber C, Lovejoy C, Wray S. Stem cell models of Alzheimer\u2019s disease: progress and challenges. Alzheimer\u2019s Res Ther. 2017;9:42.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"999_CR143","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K, et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci. 2016;19:1085\u201392.","journal-title":"Nat Neurosci"},{"key":"999_CR144","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, et al. Neuronal activity regulates extracellular tau in vivo. J Exp Med. 2014;211:387\u201393.","journal-title":"J Exp Med"},{"key":"999_CR145","doi-asserted-by":"publisher","first-page":"5281829","DOI":"10.1155\/2017\/5281829","volume":"2017","author":"A Pignataro","year":"2017","unstructured":"Pignataro A, Middei S. Trans-synaptic spread of amyloid-beta in Alzheimer\u2019s disease: paths to beta-amyloidosis. Neural Plast. 2017;2017:5281829.","journal-title":"Neural Plast"},{"key":"999_CR146","doi-asserted-by":"publisher","first-page":"10913","DOI":"10.1523\/JNEUROSCI.2922-05.2005","volume":"25","author":"DL Fortin","year":"2005","unstructured":"Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, Edwards RH. Neural activity controls the synaptic accumulation of alpha-synuclein. J Neurosci. 2005;25:10913\u201321.","journal-title":"J Neurosci"},{"key":"999_CR147","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jnc.12131","volume":"125","author":"S Paillusson","year":"2013","unstructured":"Paillusson S, Clairembault T, Biraud M, Neunlist M, Derkinderen P. Activity-dependent secretion of alpha-synuclein by enteric neurons. J Neurochem. 2013;125:512\u20137.","journal-title":"J Neurochem"},{"key":"999_CR148","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler AM, Phillips EC, Lau DH, Noble W, Hanger DP. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 2013;14:389\u201394.","journal-title":"EMBO Rep"},{"key":"999_CR149","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2015.04.043","volume":"11","author":"S Calafate","year":"2015","unstructured":"Calafate S, Buist A, Miskiewicz K, Vijayan V, Daneels G, de Strooper B, et al. Synaptic contacts enhance cell-to-cell Tau pathology propagation. Cell Rep. 2015;11:1176\u201383.","journal-title":"Cell Rep"},{"key":"999_CR150","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.celrep.2016.12.018","volume":"18","author":"P Pruunsild","year":"2017","unstructured":"Pruunsild P, Bengtson CP, Bading H. Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program. Cell Rep. 2017;18:122\u201335.","journal-title":"Cell Rep"},{"key":"999_CR151","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnins.2016.00121","volume":"10","author":"H Amin","year":"2016","unstructured":"Amin H, Maccione A, Marinaro F, Zordan S, Nieus T, Berdondini L. Electrical responses and spontaneous activity of human iPS-derived neuronal networks characterized for 3-month culture with 4096-electrode arrays. Front Neurosci. 2016;10:121.","journal-title":"Front Neurosci"},{"key":"999_CR152","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78:785\u201398.","journal-title":"Neuron"},{"key":"999_CR153","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1016\/j.celrep.2018.04.066","volume":"23","author":"R Nehme","year":"2018","unstructured":"Nehme R, Zuccaro E, Ghosh SD, Li C, Sherwood JL, Pietilainen O, et al. Combining NGN2 programming with developmental patterning generates human excitatory neurons with NMDAR-mediated synaptic transmission. Cell Rep. 2018;23:2509\u201323.","journal-title":"Cell Rep"},{"key":"999_CR154","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/cell.2014.0054","volume":"16","author":"P Koppensteiner","year":"2014","unstructured":"Koppensteiner P, Boehm S, Arancio O. Electrophysiological profiles of induced neurons converted directly from adult human fibroblasts indicate incomplete neuronal conversion. Cell Reprogram. 2014;16:439\u201346.","journal-title":"Cell Reprogram"},{"key":"999_CR155","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15252\/emmm.201607471","volume":"9","author":"J Drouin-Ouellet","year":"2017","unstructured":"Drouin-Ouellet J, Lau S, Brattas PL, Rylander Ottosson D, Pircs K, Grassi DA, et al. REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways. EMBO Mol Med. 2017;9:1117\u201331.","journal-title":"EMBO Mol Med"},{"key":"999_CR156","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nn.4297","volume":"19","author":"Y Xue","year":"2016","unstructured":"Xue Y, Qian H, Hu J, Zhou B, Zhou Y, Hu X, et al. Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells. Nat Neurosci. 2016;19:807\u201315.","journal-title":"Nat Neurosci"},{"key":"999_CR157","doi-asserted-by":"crossref","unstructured":"de Rus Jacquet A, Tancredi JL, Lemire AL, DeSantis MC, Li W-P, O\u2019Shea EK. The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson\u2019s disease. bioRxiv. 2020:178574.","DOI":"10.1101\/2020.07.02.178574"},{"key":"999_CR158","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2019.11.026","volume":"50","author":"A Birger","year":"2019","unstructured":"Birger A, Ben-Dor I, Ottolenghi M, Turetsky T, Gil Y, Sweetat S, et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274\u201389.","journal-title":"EBioMedicine"},{"key":"999_CR159","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fncel.2016.00215","volume":"10","author":"A Chandrasekaran","year":"2016","unstructured":"Chandrasekaran A, Avci HX, Leist M, Kobolak J, Dinnyes A. Astrocyte differentiation of human pluripotent stem cells: new tools for neurological disorder research. Front Cell Neurosci. 2016;10:215.","journal-title":"Front Cell Neurosci"},{"key":"999_CR160","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1002\/cpcb.98","volume":"85","author":"A de Rus Jacquet","year":"2019","unstructured":"de Rus Jacquet A. Preparation and co-culture of ipsc-derived dopaminergic neurons and astrocytes. Curr Protoc Cell Biol. 2019;85:e98.","journal-title":"Curr Protoc Cell Biol"},{"key":"999_CR161","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.stemcr.2017.06.018","volume":"9","author":"J Tcw","year":"2017","unstructured":"Tcw J, Wang M, Pimenova AA, Bowles KR, Hartley BJ, Lacin E, et al. An efficient platform for astrocyte differentiation from human induced pluripotent stem cells. Stem Cell Rep. 2017;9:600\u201314.","journal-title":"Stem Cell Rep"},{"key":"999_CR162","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.stemcr.2018.08.019","volume":"11","author":"X Li","year":"2018","unstructured":"Li X, Tao Y, Bradley R, Du Z, Tao Y, Kong L, et al. Fast generation of functional subtype astrocytes from human pluripotent stem cells. Stem Cell Rep. 2018;11:998\u20131008.","journal-title":"Stem Cell Rep"},{"key":"999_CR163","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.stemcr.2020.05.003","volume":"15","author":"A Hedegaard","year":"2020","unstructured":"Hedegaard A, Monzon-Sandoval J, Newey SE, Whiteley ES, Webber C, Akerman CJ. Pro-maturational effects of Human iPSC-derived cortical astrocytes upon iPSC-derived cortical neurons. Stem Cell Rep. 2020;15:38\u201351.","journal-title":"Stem Cell Rep"},{"key":"999_CR164","doi-asserted-by":"publisher","first-page":"dmm042317","DOI":"10.1242\/dmm.042317","volume":"13","author":"V Volpato","year":"2020","unstructured":"Volpato V, Webber C. Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility. Dis Model Mech. 2020;13:dmm042317.","journal-title":"Dis Model Mech."},{"key":"999_CR165","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41588-017-0005-8","volume":"50","author":"J Schwartzentruber","year":"2018","unstructured":"Schwartzentruber J, Foskolou S, Kilpinen H, Rodrigues J, Alasoo K, Knights AJ, et al. Molecular and functional variation in iPSC-derived sensory neurons. Nat Genet. 2018;50:54\u201361.","journal-title":"Nat Genet"},{"key":"999_CR166","doi-asserted-by":"publisher","first-page":"a005108","DOI":"10.1101\/cshperspect.a005108","volume":"3","author":"CS Barros","year":"2011","unstructured":"Barros CS, Franco SJ, Muller U. Extracellular matrix: functions in the nervous system. Cold Spring Harb Perspect Biol. 2011;3:a005108.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"999_CR167","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3389\/fphar.2019.01346","volume":"10","author":"SF Spampinato","year":"2019","unstructured":"Spampinato SF, Bortolotto V, Canonico PL, Sortino MA, Grilli M. Astrocyte-derived paracrine signals: relevance for neurogenic niche regulation and blood-brain barrier integrity. Front Pharm. 2019;10:1346.","journal-title":"Front Pharm"},{"key":"999_CR168","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tcb.2014.01.003","volume":"24","author":"TB Kornberg","year":"2014","unstructured":"Kornberg TB, Roy S. Communicating by touch\u2013neurons are not alone. Trends Cell Biol. 2014;24:370\u20136.","journal-title":"Trends Cell Biol"},{"key":"999_CR169","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1016\/j.celrep.2016.12.001","volume":"17","author":"C Luo","year":"2016","unstructured":"Luo C, Lancaster MA, Castanon R, Nery JR, Knoblich JA, Ecker JR. Cerebral organoids recapitulate epigenomic signatures of the human fetal brain. Cell Rep. 2016;17:3369\u201384.","journal-title":"Cell Rep"},{"key":"999_CR170","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrneurol.2014.178","volume":"10","author":"M Pievani","year":"2014","unstructured":"Pievani M, Filippini N, van den Heuvel MP, Cappa SF, Frisoni GB. Brain connectivity in neurodegenerative diseases\u2013from phenotype to proteinopathy. Nat Rev Neurol. 2014;10:620\u201333.","journal-title":"Nat Rev Neurol"},{"key":"999_CR171","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12929-020-00661-y","volume":"27","author":"A Vargas-Valderrama","year":"2020","unstructured":"Vargas-Valderrama A, Messina A, Mitjavila-Garcia MT, Guenou H. The endothelium, a key actor in organ development and hPSC-derived organoid vascularization. J Biomed Sci. 2020;27:67.","journal-title":"J Biomed Sci"},{"key":"999_CR172","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/WNR.0000000000001014","volume":"29","author":"MT Pham","year":"2018","unstructured":"Pham MT, Pollock KM, Rose MD, Cary WA, Stewart HR, Zhou P, et al. Generation of human vascularized brain organoids. Neuroreport. 2018;29:588\u201393.","journal-title":"Neuroreport"},{"key":"999_CR173","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","volume":"16","author":"B Cakir","year":"2019","unstructured":"Cakir B, Xiang Y, Tanaka Y, Kural MH, Parent M, Kang YJ, et al. Engineering of human brain organoids with a functional vascular-like system. Nat Methods. 2019;16:1169\u201375.","journal-title":"Nat Methods"},{"key":"999_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52204-7","volume":"9","author":"P Worsdorfer","year":"2019","unstructured":"Worsdorfer P, Dalda N, Kern A, Kruger S, Wagner N, Kwok CK, et al. Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Sci Rep. 2019;9:15663.","journal-title":"Sci Rep"},{"key":"999_CR175","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fbioe.2019.00039","volume":"7","author":"S Grebenyuk","year":"2019","unstructured":"Grebenyuk S, Ranga A. Engineering organoid vascularization. Front Bioeng Biotechnol. 2019;7:39.","journal-title":"Front Bioeng Biotechnol"},{"key":"999_CR176","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel AS, Smits LM, Hemmer K, Hachi S, Moreno EL, van Wuellen T, et al. Derivation of human midbrain-specific organoids from neuroepithelial stem cells. Stem Cell Rep. 2017;8:1144\u201354.","journal-title":"Stem Cell Rep"},{"key":"999_CR177","doi-asserted-by":"publisher","first-page":"15672","DOI":"10.1073\/pnas.1520760112","volume":"112","author":"JG Camp","year":"2015","unstructured":"Camp JG, Badsha F, Florio M, Kanton S, Gerber T, Wilsch-Brauninger M, et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. PNAS. 2015;112:15672\u20137.","journal-title":"PNAS"},{"key":"999_CR178","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501:373\u20139.","journal-title":"Nature"},{"key":"999_CR179","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pasca","year":"2015","unstructured":"Pasca AM, Sloan SA, Clarke LE, Tian Y, Makinson CD, Huber N, et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods. 2015;12:671\u20138.","journal-title":"Nat Methods"},{"key":"999_CR180","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41593-018-0316-9","volume":"22","author":"RM Marton","year":"2019","unstructured":"Marton RM, Miura Y, Sloan SA, Li Q, Revah O, Levy RJ, et al. Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures. Nat Neurosci. 2019;22:484\u201391.","journal-title":"Nat Neurosci"},{"key":"999_CR181","doi-asserted-by":"publisher","first-page":"dev166074","DOI":"10.1242\/dev.166074","volume":"146","author":"X Qian","year":"2019","unstructured":"Qian X, Song H, Ming GL. Brain organoids: advances, applications and challenges. Development. 2019;146:dev166074.","journal-title":"Development."},{"key":"999_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06684-2","volume":"9","author":"PR Ormel","year":"2018","unstructured":"Ormel PR, Vieira de Sa R, van Bodegraven EJ, Karst H, Harschnitz O, Sneeboer MAM, et al. Microglia innately develop within cerebral organoids. Nat Commun. 2018;9:4167.","journal-title":"Nat Commun"},{"key":"999_CR183","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-019-0742-2","volume":"7","author":"BR Groveman","year":"2019","unstructured":"Groveman BR, Foliaki ST, Orru CD, Zanusso G, Carroll JA, Race B, et al. Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun. 2019;7:90.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR184","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.stem.2017.07.007","volume":"21","author":"Y Xiang","year":"2017","unstructured":"Xiang Y, Tanaka Y, Patterson B, Kang YJ, Govindaiah G, Roselaar N, et al. Fusion of regionally specified hPSC-derived organoids models human brain development and interneuron migration. Cell Stem Cell. 2017;21:383\u201398 e387.","journal-title":"Cell Stem Cell"},{"key":"999_CR185","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nmeth.4304","volume":"14","author":"JA Bagley","year":"2017","unstructured":"Bagley JA, Reumann D, Bian S, Levi-Strauss J, Knoblich JA. Fused cerebral organoids model interactions between brain regions. Nat Methods. 2017;14:743\u201351.","journal-title":"Nat Methods"},{"key":"999_CR186","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.mcb.2018.03.016","volume":"145","author":"ACF Bolhaqueiro","year":"2018","unstructured":"Bolhaqueiro ACF, van Jaarsveld RH, Ponsioen B, Overmeer RM, Snippert HJ, Kops G. Live imaging of cell division in 3D stem-cell organoid cultures. Methods Cell Biol. 2018;145:91\u2013106.","journal-title":"Methods Cell Biol"},{"key":"999_CR187","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.stem.2016.12.007","volume":"20","author":"M Bershteyn","year":"2017","unstructured":"Bershteyn M, Nowakowski TJ, Pollen AA, Di Lullo E, Nene A, Wynshaw-Boris A, et al. Human iPSC-derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial glia. Cell Stem Cell. 2017;20:435\u201349 e434.","journal-title":"Cell Stem Cell"},{"key":"999_CR188","first-page":"3311","volume":"58","author":"AW Browne","year":"2017","unstructured":"Browne AW, Arnesano C, Harutyunyan N, Khuu T, Martinez JC, Pollack HA, et al. Structural and functional characterization of human stem-cell-derived retinal organoids by live imaging. Invest Ophthalmol Vis Sci. 2017;58:3311\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"999_CR189","doi-asserted-by":"publisher","first-page":"e0199918","DOI":"10.1371\/journal.pone.0199918","volume":"13","author":"M Held","year":"2018","unstructured":"Held M, Santeramo I, Wilm B, Murray P, Levy R. Ex vivo live cell tracking in kidney organoids using light sheet fluorescence microscopy. PLoS ONE. 2018;13:e0199918.","journal-title":"PLoS ONE"},{"key":"999_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/srep44939","volume":"7","author":"J Andilla","year":"2017","unstructured":"Andilla J, Jorand R, Olarte OE, Dufour AC, Cazales M, Montagner YL, et al. Imaging tissue-mimic with light sheet microscopy: a comparative guideline. Sci Rep. 2017;7:44939.","journal-title":"Sci Rep"},{"key":"999_CR191","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/s41596-019-0160-8","volume":"14","author":"JF Dekkers","year":"2019","unstructured":"Dekkers JF, Alieva M, Wellens LM, Ariese HCR, Jamieson PR, Vonk AM, et al. High-resolution 3D imaging of fixed and cleared organoids. Nat Protoc. 2019;14:1756\u201371.","journal-title":"Nat Protoc"},{"key":"999_CR192","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72:57\u201371.","journal-title":"Neuron"},{"key":"999_CR193","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ajpath.2017.01.022","volume":"187","author":"CK Nobuhara","year":"2017","unstructured":"Nobuhara CK, DeVos SL, Commins C, Wegmann S, Moore BD, Roe AD, et al. Tau antibody targeting pathological species blocks neuronal uptake and interneuron propagation of Tau in vitro. Am J Pathol. 2017;187:1399\u2013412.","journal-title":"Am J Pathol"},{"key":"999_CR194","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","volume":"7","author":"HT Tran","year":"2014","unstructured":"Tran HT, Chung CH, Iba M, Zhang B, Trojanowski JQ, Luk KC, et al. Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration. Cell Rep. 2014;7:2054\u201365.","journal-title":"Cell Rep"},{"key":"999_CR195","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1517\/17460441.2010.495116","volume":"5","author":"R Cheong","year":"2010","unstructured":"Cheong R, Paliwal S, Levchenko A. High-content screening in microfluidic devices. Expert Opin Drug Discov. 2010;5:715\u201320.","journal-title":"Expert Opin Drug Discov"},{"key":"999_CR196","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, et al. Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol. 2012;72:517\u201324.","journal-title":"Ann Neurol"},{"key":"999_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9490","volume":"6","author":"S Takeda","year":"2015","unstructured":"Takeda S, Wegmann S, Cho H, DeVos SL, Commins C, Roe AD, et al. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer\u2019s disease brain. Nat Commun. 2015;6:8490.","journal-title":"Nat Commun"},{"key":"999_CR198","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2051-5960-2-14","volume":"2","author":"S Dujardin","year":"2014","unstructured":"Dujardin S, Lecolle K, Caillierez R, Begard S, Zommer N, Lachaud C, et al. Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol Commun. 2014;2:14.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.241","volume":"5","author":"A Pal","year":"2018","unstructured":"Pal A, Glass H, Naumann M, Kreiter N, Japtok J, Sczech R, et al. High content organelle trafficking enables disease state profiling as powerful tool for disease modelling. Sci Data. 2018;5:180241.","journal-title":"Sci Data"},{"key":"999_CR200","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnins.2016.00083","volume":"10","author":"MK Lewandowska","year":"2016","unstructured":"Lewandowska MK, Radivojevic M, Jackel D, Muller J, Hierlemann AR. Cortical axons, isolated in channels, display activity-dependent signal modulation as a result of targeted stimulation. Front Neurosci. 2016;10:83.","journal-title":"Front Neurosci"},{"key":"999_CR201","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.tcb.2019.08.004","volume":"29","author":"H Bukhari","year":"2019","unstructured":"Bukhari H, Muller T. Endogenous fluorescence tagging by CRISPR. Trends Cell Biol. 2019;29:912\u201328.","journal-title":"Trends Cell Biol"},{"key":"999_CR202","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","volume":"20","author":"A Pickar-Oliver","year":"2019","unstructured":"Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019;20:490\u2013507.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"999_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04252-2","volume":"9","author":"M Adli","year":"2018","unstructured":"Adli M. The CRISPR tool kit for genome editing and beyond. Nat Commun. 2018;9:1911.","journal-title":"Nat Commun"},{"key":"999_CR204","doi-asserted-by":"publisher","first-page":"e0154604","DOI":"10.1371\/journal.pone.0154604","volume":"11","author":"L Kaczmarczyk","year":"2016","unstructured":"Kaczmarczyk L, Mende Y, Zevnik B, Jackson WS. Manipulating the prion protein gene sequence and expression levels with CRISPR\/Cas9. PLoS ONE. 2016;11:e0154604.","journal-title":"PLoS ONE"},{"key":"999_CR205","doi-asserted-by":"publisher","first-page":"18952","DOI":"10.1074\/jbc.RA119.009432","volume":"294","author":"JJ Chen","year":"2019","unstructured":"Chen JJ, Nathaniel DL, Raghavan P, Nelson M, Tian R, Tse E, et al. Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation. J Biol Chem. 2019;294:18952\u201366.","journal-title":"J Biol Chem"},{"key":"999_CR206","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0418-y","volume":"15","author":"AM Rice","year":"2017","unstructured":"Rice AM, McLysaght A. Dosage-sensitive genes in evolution and disease. BMC Biol. 2017;15:78.","journal-title":"BMC Biol"},{"key":"999_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5755","volume":"5","author":"EJ Bae","year":"2014","unstructured":"Bae EJ, Yang NY, Song M, Lee CS, Lee JS, Jung BC, et al. Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein. Nat Commun. 2014;5:4755.","journal-title":"Nat Commun"},{"key":"999_CR208","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/acschembio.7b00657","volume":"13","author":"M Kampmann","year":"2018","unstructured":"Kampmann M. CRISPRi and CRISPRa screens in mammalian cells for precision biology and medicine. ACS Chem Biol. 2018;13:406\u201316.","journal-title":"ACS Chem Biol"},{"key":"999_CR209","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/hum.2013.200","volume":"25","author":"LM Stanek","year":"2014","unstructured":"Stanek LM, Sardi SP, Mastis B, Richards AR, Treleaven CM, Taksir T, et al. Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington\u2019s disease. Hum Gene Ther. 2014;25:461\u201374.","journal-title":"Hum Gene Ther"},{"key":"999_CR210","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Tay Y, Sim B, Yoon SI, Huang Y, Ooi J, et al. Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep. 2017;8:619\u201333.","journal-title":"Stem Cell Rep"},{"key":"999_CR211","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ejn.14286","volume":"49","author":"Y Chen","year":"2019","unstructured":"Chen Y, Dolt KS, Kriek M, Baker T, Downey P, Drummond NJ, et al. Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene. Eur J Neurosci. 2019;49:510\u201324.","journal-title":"Eur J Neurosci"},{"key":"999_CR212","doi-asserted-by":"publisher","first-page":"42991","DOI":"10.1038\/srep42991","volume":"7","author":"AL Hallmann","year":"2017","unstructured":"Hallmann AL, Arauzo-Bravo MJ, Mavrommatis L, Ehrlich M, Ropke A, Brockhaus J, et al. Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein. Sci Rep. 2017;7:42991.","journal-title":"Sci Rep"},{"key":"999_CR213","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1093\/hmg\/ddx331","volume":"26","author":"SM Heman-Ackah","year":"2017","unstructured":"Heman-Ackah SM, Manzano R, Hoozemans JJM, Scheper W, Flynn R, Haerty W, et al. Alpha-synuclein induces the unfolded protein response in Parkinson\u2019s disease SNCA triplication iPSC-derived neurons. Hum Mol Genet. 2017;26:4441\u201350.","journal-title":"Hum Mol Genet"},{"key":"999_CR214","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","volume":"146","author":"F Soldner","year":"2011","unstructured":"Soldner F, Laganiere J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 2011;146:318\u201331.","journal-title":"Cell"},{"key":"999_CR215","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","volume":"12","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt P, Schmid B, Burbulla LF, Schondorf DC, Wagner L, Glatza M, et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013;12:354\u201367.","journal-title":"Cell Stem Cell"},{"key":"999_CR216","doi-asserted-by":"publisher","first-page":"26846","DOI":"10.1073\/pnas.1907081116","volume":"116","author":"J Jackow","year":"2019","unstructured":"Jackow J, Guo Z, Hansen C, Abaci HE, Doucet YS, Shin JU, et al. CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells. PNAS. 2019;116:26846\u201352.","journal-title":"PNAS"},{"key":"999_CR217","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.1093\/nar\/gky804","volume":"46","author":"XL Li","year":"2018","unstructured":"Li XL, Li GH, Fu J, Fu YW, Zhang L, Chen W, et al. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression. Nucleic Acids Res. 2018;46:10195\u2013215.","journal-title":"Nucleic Acids Res"},{"key":"999_CR218","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","volume":"24","author":"CA Vakulskas","year":"2018","unstructured":"Vakulskas CA, Dever DP, Rettig GR, Turk R, Jacobi AM, Collingwood MA, et al. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nat Med. 2018;24:1216\u201324.","journal-title":"Nat Med"},{"key":"999_CR219","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1126\/science.1675487","volume":"252","author":"SB Prusiner","year":"1991","unstructured":"Prusiner SB. Molecular biology of prion diseases. Science. 1991;252:1515\u201322.","journal-title":"Science"},{"key":"999_CR220","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00335-002-3043-0","volume":"13","author":"E Makrinou","year":"2002","unstructured":"Makrinou E, Collinge J, Antoniou M. Genomic characterization of the human prion protein (PrP) gene locus. Mamm Genome. 2002;13:696\u2013703.","journal-title":"Mamm Genome"},{"key":"999_CR221","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2013.11.010","volume":"35","author":"M Schmitz","year":"2014","unstructured":"Schmitz M, Lullmann K, Zafar S, Ebert E, Wohlhage M, Oikonomou P, et al. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Neurobiol Aging. 2014;35:1177\u201388.","journal-title":"Neurobiol Aging"},{"key":"999_CR222","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1523\/JNEUROSCI.2294-09.2009","volume":"29","author":"PN Giannopoulos","year":"2009","unstructured":"Giannopoulos PN, Robertson C, Jodoin J, Paudel H, Booth SA, LeBlanc AC. Phosphorylation of prion protein at serine 43 induces prion protein conformational change. J Neurosci. 2009;29:8743\u201351.","journal-title":"J Neurosci"},{"key":"999_CR223","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.1073\/pnas.95.14.8322","volume":"95","author":"P Parchi","year":"1998","unstructured":"Parchi P, Chen SG, Brown P, Zou W, Capellari S, Budka H, et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. PNAS. 1998;95:8322\u20137.","journal-title":"PNAS"},{"key":"999_CR224","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bpa.12695","volume":"29","author":"S Baiardi","year":"2019","unstructured":"Baiardi S, Rossi M, Capellari S, Parchi P. Recent advances in the histo-molecular pathology of human prion disease. Brain Pathol. 2019;29:278\u2013300.","journal-title":"Brain Pathol"},{"key":"999_CR225","doi-asserted-by":"publisher","first-page":"20711","DOI":"10.1074\/jbc.M112.364067","volume":"287","author":"Q Zhong","year":"2012","unstructured":"Zhong Q, Congdon EE, Nagaraja HN, Kuret J. Tau isoform composition influences rate and extent of filament formation. J Biol Chem. 2012;287:20711\u20139.","journal-title":"J Biol Chem"},{"key":"999_CR226","doi-asserted-by":"publisher","first-page":"e0195771","DOI":"10.1371\/journal.pone.0195771","volume":"13","author":"MM Hefti","year":"2018","unstructured":"Hefti MM, Farrell K, Kim S, Bowles KR, Fowkes ME, Raj T, et al. High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development. PLoS ONE. 2018;13:e0195771.","journal-title":"PLoS ONE"},{"key":"999_CR227","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1523\/JNEUROSCI.2305-16.2016","volume":"37","author":"V Lacovich","year":"2017","unstructured":"Lacovich V, Espindola SL, Alloatti M, Pozo Devoto V, Cromberg LE, Carna ME, et al. Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons. J Neurosci. 2017;37:58\u201369.","journal-title":"J Neurosci"},{"key":"999_CR228","doi-asserted-by":"publisher","first-page":"e84849","DOI":"10.1371\/journal.pone.0084849","volume":"8","author":"C Liu","year":"2013","unstructured":"Liu C, Gotz J. Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus. PLoS ONE. 2013;8:e84849.","journal-title":"PLoS ONE."},{"key":"999_CR229","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","volume":"6","author":"J Neddens","year":"2018","unstructured":"Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T, et al. Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6:52.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR230","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s40478-019-0823-2","volume":"7","author":"E Ercan-Herbst","year":"2019","unstructured":"Ercan-Herbst E, Ehrig J, Schondorf DC, Behrendt A, Klaus B, Gomez Ramos B, et al. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer\u2019s disease brain. Acta Neuropathol Commun. 2019;7:192.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR231","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fneur.2019.00980","volume":"10","author":"A Katsumoto","year":"2019","unstructured":"Katsumoto A, Takeuchi H, Tanaka F. Tau pathology in chronic traumatic encephalopathy and Alzheimer\u2019s disease: similarities and differences. Front Neurol. 2019;10:980.","journal-title":"Front Neurol"},{"key":"999_CR232","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","volume":"12","author":"NR Barthelemy","year":"2020","unstructured":"Barthelemy NR, Bateman RJ, Hirtz C, Marin P, Becher F, Sato C, et al. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification. Alzheimer\u2019s Res Ther. 2020;12:26.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"999_CR233","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2019.00121","volume":"11","author":"NR Barthelemy","year":"2019","unstructured":"Barthelemy NR, Mallipeddi N, Moiseyev P, Sato C, Bateman RJ. Tau phosphorylation rates measured by mass spectrometry differ in the intracellular brain vs. extracellular cerebrospinal fluid compartments and are differentially affected by Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:121.","journal-title":"Front Aging Neurosci"},{"issue":"Pt 7","key":"999_CR234","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/brain\/awv107","volume":"138","author":"R Vuono","year":"2015","unstructured":"Vuono R, Winder-Rhodes S, de Silva R, Cisbani G, Drouin-Ouellet J, Network RIotEHsD. et al. The role of tau in the pathological process and clinical expression of Huntington\u2019s disease. Brain. 2015;138(Pt 7):1907\u201318.","journal-title":"Brain"},{"key":"999_CR235","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/156720510791050902","volume":"7","author":"JR Bamburg","year":"2010","unstructured":"Bamburg JR, Bernstein BW, Davis RC, Flynn KC, Goldsbury C, Jensen JR, et al. ADF\/Cofilin-actin rods in neurodegenerative diseases. Curr Alzheimer Res. 2010;7:241\u201350.","journal-title":"Curr Alzheimer Res"},{"key":"999_CR236","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1073\/pnas.94.8.4113","volume":"94","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. PNAS. 1997;94:4113\u20138.","journal-title":"PNAS"},{"key":"999_CR237","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","volume":"73","author":"I Ferrer","year":"2014","unstructured":"Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, et al. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol. 2014;73:81\u201397.","journal-title":"J Neuropathol Exp Neurol"},{"key":"999_CR238","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","volume":"99","author":"KH Strang","year":"2019","unstructured":"Strang KH, Golde TE, Giasson BI. MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest. 2019;99:912\u201328.","journal-title":"Lab Invest"},{"key":"999_CR239","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11011-019-00516-y","volume":"35","author":"YQ Leong","year":"2020","unstructured":"Leong YQ, Ng KY, Chye SM, Ling APK, Koh RY. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Metab Brain Dis. 2020;35:11\u201330.","journal-title":"Metab Brain Dis"},{"key":"999_CR240","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11359","volume":"7","author":"N Rezaei-Ghaleh","year":"2016","unstructured":"Rezaei-Ghaleh N, Amininasab M, Kumar S, Walter J, Zweckstetter M. Phosphorylation modifies the molecular stability of beta-amyloid deposits. Nat Commun. 2016;7:11359.","journal-title":"Nat Commun"},{"key":"999_CR241","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-016-1546-0","volume":"131","author":"S Kumar","year":"2016","unstructured":"Kumar S, Wirths O, Stuber K, Wunderlich P, Koch P, Theil S, et al. Phosphorylation of the amyloid beta-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity. Acta Neuropathol. 2016;131:525\u201337.","journal-title":"Acta Neuropathol"},{"key":"999_CR242","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, Walter J, Saido TC, Fandrich M. Neuropathology and biochemistry of Abeta and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol. 2015;129:167\u201382.","journal-title":"Acta Neuropathol"},{"key":"999_CR243","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/pin.12520","volume":"67","author":"RH Takahashi","year":"2017","unstructured":"Takahashi RH, Nagao T, Gouras GK. Plaque formation and the intraneuronal accumulation of beta-amyloid in Alzheimer\u2019s disease. Pathol Int. 2017;67:185\u201393.","journal-title":"Pathol Int"},{"key":"999_CR244","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, Iwasyk JE, Maghames CM, Meymand ES, et al. Amyloid-Beta (Abeta) plaques promote seeding and spreading of alpha-synuclein and Tau in a mouse model of lewy body disorders with abeta pathology. Neuron. 2020;105:260\u201375 e266.","journal-title":"Neuron"},{"key":"999_CR245","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/ijms17030338","volume":"17","author":"YS Batarseh","year":"2016","unstructured":"Batarseh YS, Duong QV, Mousa YM, Al Rihani SB, Elfakhri K, Kaddoumi A. Amyloid-beta and astrocytes interplay in amyloid-beta related disorders. Int J Mol Sci. 2016;17:338.","journal-title":"Int J Mol Sci"},{"key":"999_CR246","first-page":"444","volume":"8","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Hurtig HI. The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. JADP. 2018;8:444.","journal-title":"JADP."},{"key":"999_CR247","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"key":"999_CR248","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet. 2009;41:1308\u201312.","journal-title":"Nat Genet"},{"key":"999_CR249","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12035-012-8330-5","volume":"47","author":"K Beyer","year":"2013","unstructured":"Beyer K, Ariza A. Alpha-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Mol Neurobiol. 2013;47:509\u201324.","journal-title":"Mol Neurobiol"},{"key":"999_CR250","doi-asserted-by":"publisher","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","volume":"8","author":"J Burre","year":"2018","unstructured":"Burre J, Sharma M, Sudhof TC. Cell biology and pathophysiology of alpha-Synuclein. Cold Spring Harb Perspect Med. 2018;8:a024091.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 1","key":"999_CR251","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jnc.13249","volume":"139","author":"A Villar-Pique","year":"2016","unstructured":"Villar-Pique A, Lopes da Fonseca T, Outeiro TF. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies. J Neurochem. 2016;139(Suppl 1):240\u201355.","journal-title":"J Neurochem"},{"key":"999_CR252","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.26479","volume":"31","author":"L Calo","year":"2016","unstructured":"Calo L, Wegrzynowicz M, Santivanez-Perez J, Grazia, Spillantini M. Synaptic failure and alpha-synuclein. Mov Disord. 2016;31:169\u201377.","journal-title":"Mov Disord"},{"issue":"Pt B","key":"999_CR253","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Lee VM. Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies. Neurobiol Dis. 2018;109(Pt B):209\u201318.","journal-title":"Neurobiol Dis"},{"key":"999_CR254","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72:971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"999_CR255","doi-asserted-by":"publisher","first-page":"e0127687","DOI":"10.1371\/journal.pone.0127687","volume":"10","author":"A Ruzo","year":"2015","unstructured":"Ruzo A, Ismailoglu I, Popowski M, Haremaki T, Croft GF, Deglincerti A, et al. Discovery of novel isoforms of huntingtin reveals a new hominid-specific exon. PLoS ONE. 2015;10:e0127687.","journal-title":"PLoS ONE"},{"key":"999_CR256","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JHD-150151","volume":"4","author":"M Mort","year":"2015","unstructured":"Mort M, Carlisle FA, Waite AJ, Elliston L, Allen ND, Jones L, et al. Huntingtin exists as multiple splice forms in human brain. J Huntington\u2019s Dis. 2015;4:161\u201371.","journal-title":"J Huntington\u2019s Dis"},{"key":"999_CR257","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01510-z","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder A, Landles C, Ghosh R, Howland D, Myers RH, Faull RLM, et al. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci Rep. 2017;7:1307.","journal-title":"Sci Rep"},{"key":"999_CR258","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JHD-180292","volume":"7","author":"L Romo","year":"2018","unstructured":"Romo L, Mohn ES, Aronin N. A fresh look at huntingtin mRNA processing in Huntington\u2019s disease. J Huntington\u2019s Dis. 2018;7:101\u20138.","journal-title":"J Huntington\u2019s Dis"},{"key":"999_CR259","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1073858410390378","volume":"17","author":"DE Ehrnhoefer","year":"2011","unstructured":"Ehrnhoefer DE, Sutton L, Hayden MR. Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist. 2011;17:475\u201392.","journal-title":"Neuroscientist"},{"key":"999_CR260","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ana.24174","volume":"76","author":"F Cicchetti","year":"2014","unstructured":"Cicchetti F, Lacroix S, Cisbani G, Vallieres N, Saint-Pierre M, St-Amour I, et al. Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann Neurol. 2014;76:31\u201342.","journal-title":"Ann Neurol"},{"key":"999_CR261","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-019-0726-2","volume":"7","author":"M Hartlage-Rubsamen","year":"2019","unstructured":"Hartlage-Rubsamen M, Ratz V, Zeitschel U, Finzel L, Machner L, Koppen J, et al. Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2019;7:79.","journal-title":"Acta Neuropathol Commun"},{"key":"999_CR262","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59\u201362.","journal-title":"Nature"},{"key":"999_CR263","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1749-6632.1985.tb21489.x","volume":"450","author":"Y Groner","year":"1985","unstructured":"Groner Y, Lieman-Hurwitz J, Dafni N, Sherman L, Levanon D, Bernstein Y, et al. Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu\/Zn superoxide dismutase and its relevance to Down syndrome. Ann NY Acad Sci. 1985;450:133\u201356.","journal-title":"Ann NY Acad Sci"},{"key":"999_CR264","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1212\/01.wnl.0000345363.65799.35","volume":"72","author":"L Zinman","year":"2009","unstructured":"Zinman L, Liu HN, Sato C, Wakutani Y, Marvelle AF, Moreno D, et al. A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology. 2009;72:1153\u20139.","journal-title":"Neurology"},{"key":"999_CR265","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.str.2016.08.011","volume":"24","author":"JM Fay","year":"2016","unstructured":"Fay JM, Zhu C, Proctor EA, Tao Y, Cui W, Ke H, et al. A phosphomimetic mutation stabilizes SOD1 and rescues cell viability in the context of an ALS-associated mutation. Structure. 2016;24:1898\u2013906.","journal-title":"Structure"},{"key":"999_CR266","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/neup.12324","volume":"37","author":"H Jiang","year":"2017","unstructured":"Jiang H, Shimizu H, Shiga A, Tanaka M, Onodera O, Kakita A, et al. Familial amyotrophic lateral sclerosis with an I104F mutation in the SOD1 gene: Multisystem degeneration with neurofilamentous aggregates and SOD1 inclusions. Neuropathology. 2017;37:69\u201377.","journal-title":"Neuropathology"},{"key":"999_CR267","doi-asserted-by":"crossref","first-page":"458427","DOI":"10.1155\/2011\/458427","volume":"2011","author":"P Milani","year":"2011","unstructured":"Milani P, Gagliardi S, Cova E, Cereda C. SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS. Neurol Res Int. 2011;2011:458427.","journal-title":"Neurol Res Int"},{"key":"999_CR268","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25.","journal-title":"Front Mol Neurosci"},{"key":"999_CR269","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1412-5","volume":"130","author":"S Xiao","year":"2015","unstructured":"Xiao S, Sanelli T, Chiang H, Sun Y, Chakrabartty A, Keith J, et al. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Acta Neuropathol. 2015;130:49\u201361.","journal-title":"Acta Neuropathol"},{"key":"999_CR270","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64:60\u201370.","journal-title":"Ann Neurol"},{"key":"999_CR271","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00401-012-1055-8","volume":"125","author":"JL Robinson","year":"2013","unstructured":"Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, et al. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125:121\u201331.","journal-title":"Acta Neuropathol"},{"key":"999_CR272","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00401-008-0408-9","volume":"116","author":"WL Lin","year":"2008","unstructured":"Lin WL, Dickson DW. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 2008;116:205\u201313.","journal-title":"Acta Neuropathol"}],"updated-by":[{"DOI":"10.1038\/s41380-021-01055-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000}}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-00999-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-00999-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-00999-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T01:42:09Z","timestamp":1697679729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-00999-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":272,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1038\/s41380-020-00999-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41380-021-01055-8","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41380-021-01055-8","URL":"https:\/\/doi.org\/10.1038\/s41380-021-01055-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}